193 related articles for article (PubMed ID: 10424115)
21. Senate defeats action to expand Medicare drug coverage.
AIDS Policy Law; 2001 May; 16(9):2. PubMed ID: 11668824
[No Abstract] [Full Text] [Related]
22. What are fairness and consistency in a national pharmacy benefit?
Daniels N; Sabin JE
Med Care; 2001 Apr; 39(4):312-4. PubMed ID: 11329518
[No Abstract] [Full Text] [Related]
23. Clinton proposal begins debate on Medicare prescription benefit.
Weiss HP
Balance; 1999; 3(5):6-7. PubMed ID: 10662381
[No Abstract] [Full Text] [Related]
24. Part I--Medicare prescription drug coverage (Part D): the promise.
Witten B
Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
[No Abstract] [Full Text] [Related]
25. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
26. A bitter pill: the new Medicare prescription drug benefit.
Siegel S
Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
[No Abstract] [Full Text] [Related]
27. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
28. The new Medicare prescription-drug legislation.
Altman DE
N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422
[No Abstract] [Full Text] [Related]
29. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
Shea DG; Stuart BC; Briesacher B
Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
[No Abstract] [Full Text] [Related]
30. Seniors finally get help. Drug support limited by 'doughnut hole,' costs.
Mantone J; Tieman J
Mod Healthc; 2003 Dec 22-29; 33(51):30-1. PubMed ID: 14723088
[No Abstract] [Full Text] [Related]
31. Who'll get soaked if Medicare covers drugs?
Moskowitz DB
Bus Health; 2000; 18(10):33-5, 38. PubMed ID: 11213766
[No Abstract] [Full Text] [Related]
32. Catastrophic health insurance: budget and policy issues.
Helms RB
Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
[No Abstract] [Full Text] [Related]
33. In Beltway, all eyes are on drug benefit.
Gardner J
Mod Healthc; 2000 May; 30(21):44. PubMed ID: 11067548
[No Abstract] [Full Text] [Related]
34. How should Medicare structure drug benefits?
Frenkel M
J Med Pract Manage; 1999; 15(1):5-6. PubMed ID: 10662277
[No Abstract] [Full Text] [Related]
35. Discounts on your Rx drugs.
Quinn JB
Newsweek; 2001 Aug; 138(6):25. PubMed ID: 11499272
[No Abstract] [Full Text] [Related]
36. Medicare Part D drug benefit and HIV/AIDS: questions and answers.
Valenti WM
AIDS Read; 2006 Feb; 16(2):66, 70-1. PubMed ID: 16471271
[TBL] [Abstract][Full Text] [Related]
37. Private, individual drug coverage in the current Medicare market.
Boccuti C; Moon M
Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
[No Abstract] [Full Text] [Related]
38. Medicare's spin cycle.
Bloice C
Revolution (Oakl); 2002; 3(2):4-5. PubMed ID: 11949233
[No Abstract] [Full Text] [Related]
39. Life without the venipuncture benefit: one agency's experience.
Magruder J; Legeay S
Caring; 1999 Apr; 18(4):46-8, 50. PubMed ID: 10537511
[TBL] [Abstract][Full Text] [Related]
40. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
